Procurement Summary
Country : USA
Summary : Midazolam Autoinjectors Project Bioshield
Deadline : 30 Jul 2021
Other Information
Notice Type : Tender
TOT Ref.No.: 54788552
Document Ref. No. : 75A50121R00003
Competition : ICB
Financier : Self Financed
Purchaser Ownership : -
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Midazolam Autoinjectors Project Bioshield
Active Contract Opportunity
Notice ID : 75A50121R00003
Related Notice : 75A50121R00003
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office : ASPR BARDA DIV CONTRACTS MGMT & ACQ
General Information
Contract Opportunity Type: Solicitation (Updated)
All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
Updated Published Date: Jul 02, 2021 04:28 pm EDT
Original Published Date: Jun 17, 2021 12:39 pm EDT
Updated Date Offers Due: Jul 30, 2021 04:00 pm EDT
Original Date Offers Due: Jul 19, 2021 04:00 pm EDT
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Aug 14, 2021
Original Inactive Date: Aug 03, 2021
Initiative: None
Classification
Original Set Aside:
Product Service Code: AN11 - Health R&D Services; Health care services; Basic Research
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Place of Performance:
Description
This Request for Proposal (RFP) covers the advanced research and development, procurement, and delivery of adult and pediatric midazolam autoinjectors that have received FDA approval for the treatment of status epilepticus seizures (including seizures caused by nerve agents) in adult and pediatric populations (2+ years of age).
Please see at...
Documents
Tender Notice